Annals of Hepatology

Article	Citations
A multisociety Delphi consensus statement on new fatty liver disease nomenclature	183
STAT3: A key regulator in liver fibrosis	95
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease	79
Liver disease and outcomes among COVID-19 hospitalized patients – A systematic review and meta-analysis	71
Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article	67
Clinical treatment of cholangiocarcinoma: an updated comprehensive review	60
Chemotherapy-associated steatohepatitis	56
The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies	54
The effect of liver test abnormalities on the prognosis of COVID-19	49
Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)	48
A systematic review and meta-analysis of the COVID-19 associated liver injury	44
Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C	42
Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases	38
From Child-Pugh to MELD score and beyond: Taking a walk down memory lane	36
Silymarin is an ally against insulin resistance: A review	36
The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study	35
Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) III	32
Standardization of conventional chemoembolization for hepatocellular carcinoma	30
The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formation	29
COVID-19 and the liver: What do we know after six months of the pandemic?	29
An Integrated Review of the Hepatorenal Syndrome	28
Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease	28
Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population	27
SARS-CoV-2 another kind of liver aggressor, how does it do that?	27
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis	26

Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission	25
Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysis	24
Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver	24
Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease	23
LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway	22
Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy	22
Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis	21
NAFLD: Challenges and opportunities to address the public health problem in Latin America	21
Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study	20
Salvianolic acid B blocks hepatic stellate cell activation via FGF19/FGFR4 signaling	20
Frailty and reduced gait speed are independently related to mortality of cirrhotic patients in long-term follow-up	20
Prognostic value of liver biochemical parameters for COVID-19 mortality	19
A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019)	19
Gender disparity in hepatocellular carcinoma recurrence after curative hepatectomy	19
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases	18
MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3	18
Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study	18
Acid-base abnormalities and liver dysfunction	18
Renal and brain failure predict mortality of patients with acute-on-chronic liver failure admitted to the intensive care unit	17
Albumin in the management of hepatic encephalopathy: A systematic review and meta-analysis	17
MicroRNA-494-3p prevents liver fibrosis and attenuates hepatic stellate cell activation by inhibiting proliferation and inducing apoptosis through targeting TRAF3	17
Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways	17
Carcinoembryonic antigen, α-fetoprotein, and Ki67 as biomarkers and prognostic factors in intrahepatic cholangiocarcinoma: A retrospective cohort study	17
NAFLD VS MAFLD. The evidence-based debate has come. Time to change?	17
Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis	17
Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis	17
miR-221-3p regulates hepatocellular carcinoma cell proliferation, migration and invasion via targeting LIFR	16
Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway	15
Prevalence and impact of Sjögren's syndrome in primary biliary cholangitis: a systematic review and meta-analysis	15
Management of hepatocellular carcinoma recurrence after liver transplantation	15
LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p	14
The histone variant H3.3 regulates the transcription of the hepatitis B virus	14
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study	14
Health-related quality of life in Cuban patients with chronic liver disease: A real-world experience	14
Zinc supplementation and its benefits in the management of chronic liver disease: An in-depth literature review	14
Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection	14
N-acetyl cysteine versus standard of care for non-acetaminophen induced acute liver injury: a systematic review and meta-analysis	14
Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network	14
Management of COVID-19 patients with chronic liver diseases and liver transplants	13
FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseases	13
Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway	13
miRNA-338-3p/CAMK IIα signaling pathway prevents acetaminophen-induced acute liver inflammation in vivo	13
Effects of chronic HBV infection on lipid metabolism in non-alcoholic fatty liver disease: A lipidomic analysis	13
Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis	13
Spleen stiffness can be employed to assess the efficacy of spontaneous portosystemic shunts in relieving portal hypertension	12
Hepatitis B virus in Lao dentists: A cross-sectional serological study	12
Evaluation of drug-induced liver injury as etiology for acute liver failure in Brazil	12
Position statement on the use of albumin in liver cirrhosis	12
Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in Mexico	12
Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis	12

Ocular manifestations of liver disease in children: Clinical aspects and implications	12
Liquid biopsy in chronic liver disease	12
Hepatic steatosis and respiratory diseases: a new panorama	12
Liver function as a predictor of mortality in COVID-19: A retrospective study	12
The impact of COVID-19 on the cascade of care of HCV in the US and China	12
The impact of electronic medical record system implementation on HCV screening and continuum of care: a systematic review	11
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence	11
IGF-1 contributes to liver cancer development in diabetes patients by promoting autophagy	11
LINC01006 regulates the proliferation, migration and invasion of hepatocellular carcinoma cells through regulating miR-433-3p/CBX3 axis	11
LI-RADS 4 or 5 categorization may not be clinically relevant for decision-making processes: A prospective cohort study	11
Safety and efficacy of dyslipidemia treatment in NAFLD patients: a meta-analysis of randomized controlled trials	11
Real-World Effectiveness of Direct-Acting Antiviral Regimens against Hepatitis C Virus (HCV) Genotype 3 Infection: A Systematic Review and Meta-Analysis	11
Effect of bile acids on the expression of MRP3 and MRP4: An In vitro study in HepG2 cell line	11
Effects of cytomegalovirus infection on the differential diagnosis between biliary atresia and intrahepatic cholestasis in a Chinese large cohort study	11
Waitlist mortality and transplant free survival in Hispanic patients listed for liver transplant using the UNOS database	10
Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease	10
Alternative splicing and liver disease	10
Infected hepatic echinococcosis. Clinical, therapeutic, and prognostic aspects. A systematic review	10
Possible roles of Golgi protein-73 in liver diseases	10
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis	10
Granulocyte colony stimulating factor: A potential therapeutic rescue in severe alcoholic hepatitis and decompensated cirrhosis	10
HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation	10
Dysregulated N6-methyladenosine (m6A) processing in hepatocellular carcinoma	10
Circ_0078710 promotes the development of liver cancer by upregulating TXNDC5 via miR-431-5p	10
Hepatitis B core related antigen in relation to intrahepatic and circulating viral markers, before and after combination therapy	10
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany	10
Characteristics and outcomes of hospitalized patients with Wilson’s disease in the United States: A national survey	9
Early living donor liver transplantation for alcohol-associated hepatitis	9
Hepatitis E virus superinfection impairs long-term outcome in hospitalized patients with hepatitis B virus-related decompensated liver cirrhosis	9
Mineralocorticoid receptor modulation by dietary sodium influences NAFLD development in mice	9
Anti-hepatitis B virus activity of food nutrients and potential mechanisms of action	9
Ras related GTP binding D promotes aerobic glycolysis of hepatocellular carcinoma	9
Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus	9
Clinical features and treatment outcomes of primary biliary cholangitis in a highly admixed population	9
Long noncoding RNA LINC01189 is associated with HCV-hepatocellular carcinoma and regulates cancer cell proliferation and chemoresistance through hsa-miR-155-5p	9
Radiofrequency ablation and percutaneous ethanol injection versus radiofrequency ablation alone for hepatocellular carcinoma: a systematic review and meta-analysis	9
Current approaches to hepatic encephalopathy	9
A hospital-based study of the prevalence of HBV, HCV, HIV, and liver disease among a low-income population in West Mexico	9
Metabolic dysfunction: The silenced connection with fatty liver disease	9
Latin America and chronic diseases: A perfect storm during the COVID-19 pandemic	8
Progression of intraductal papillary neoplasm of the bile duct (IPNB): A proposed model through the observation of patients with non-resected tumors	8
Ubiquitin-specific protease 1 acts as an oncogene and promotes lenvatinib efficacy in hepatocellular carcinoma by stabilizing c-kit	8
Temporal histopathological changes in biliary atresia: A perspective for rapid fibrosis progression	8
Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease	8
Elevated lactate/albumin ratio as a novel predictor of in-hospital mortality in hospitalized cirrhotics	8
Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay	8
African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population	8
Role of CD98 in liver disease	8
IGF-1 alleviates CCL4-induced hepatic cirrhosis and dysfunction of intestinal barrier through inhibition TLR4/NF-κB signaling mediated by down-regulation HMGB1	8
Circ-LARP1B knockdown restrains the tumorigenicity and enhances radiosensitivity by regulating miR-578/IGF1R axis in hepatocellular carcinoma	8
EncephalApp Stroop Test validation for the screening of minimal hepatic encephalopathy in Brazil	7
Outcomes of liver transplantation in patients 70 years or older: a systematic review and meta-analysis	7
Horizon scanning of therapeutic modalities for nonalcoholic steatohepatitis	7
Hepatitis B virus genotypes and subgenotypes and the natural history and epidemiology of hepatitis B	7
Alcohol-associated liver disease: Epidemiology and management	7
Liver diseases: Perspective from the Philippines	7
Clinical efficacy and safety of external radiotherapy combined with sorafenib in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis	7
The impact of direct-acting antivirals on quality of life in patients with hepatitis C virus infection: a meta-analysis	7
Liver resection for single large hepatocellular carcinoma: a prognostic factors study	7
LncRNA EPIC1 promotes proliferation and inhibits apoptosis of gallbladder cancer cells by interacting with LET	7
Artificial liver support system in pediatric acute liver failure due to mushroom poisoning: Case series	7
Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1–6 in Brazil	7
Endurance exercise-mediated metabolic reshuffle attenuates high-caloric diet-induced non-alcoholic fatty liver disease	7
Failure in all steps of hepatocellular carcinoma surveillance process is frequent in daily practice	7
MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease	7
A fat containing combined neuroendocrine carcinoma and hepatocellular carcinoma in the liver: A case report	7
What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease?	6
The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population	6
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up study	6
MiR-3682 promotes the progression of hepatocellular carcinoma (HCC) via inactivating AMPK signaling by targeting ADRA1A	6
Introduction of a standardized protocol for cardiac risk assessment in candidates for liver transplant – A retrospective cohort analysis	6
Characteristics and in-hospital outcomes of COVID-19 patients with abnormal liver biochemical tests	6
Increased access to liver transplantation for patients with acute on chronic liver failure after implementation of Share 35 Rule: An analysis from the UNOS database	6
Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up	6
An Outbreak Presents An Opportunity to Learn About A Rare Phenotype: Autoimmune Hepatitis After Acute Hepatitis A	6
Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy	6
Hepatic immune-mediatedadverseeffects of immune checkpoint inhibitors: analysis of real-life experience	6
Activation of the NLRP3 inflammasome by CCl4 exacerbates hepatopathogenic diet-induced experimental NASH	6
PNPLA3 rs738409 associates with alcoholic liver cirrhosis but not with serum levels of IL6, IL10, IL8 or CCL2 in the Russian population	6
Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study	6

A novel non-invasive score for the prediction of advanced fibrosis in patients with chronic hepatitis B	6
Waitlist mortality in patients with autoimmune liver diseases	6
Association between klotho and non-alcoholic fatty liver disease and liver fibrosis based on the NHANES 2007–2016	6
Post-liver transplant outcomes in patients with major psychiatric diagnosis in the United States	5
Immunotolerance in liver transplantation: a primer for the clinician	5
Splenic vein embolization as a feasible treatment for patients with hepatic encephalopathy related to large spontaneous splenorenal shunts	5
Progress of targeted and immunotherapy for hepatocellular carcinoma and the application of next-generation sequencing	5
A thorny matter: Spur cell anemia	5
Clinical application of Magnetic resonance elastography in hepatocellular carcinoma: from diagnosis to prognosis	5
Cerebral hemodynamics in the non-alcoholic fatty liver	5
The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids	5
Laparoscopic cholecystectomy: Histopathological analysis of metabolic associated fatty liver disease and fibrosis	5
Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016	5
The treatment of diabetes in advanced liver disease: change of a paradigm	5
New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD	5
Pregnancy in Chronic Liver Disease: Before and After Transplantation	5
Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: a propensity-score matched-cohort study	5
Improvement of renal function prior to liver transplantation is not associated with better long-term renal outcome or survival	5
Simultaneous Metabolic and Alcohol-associated Fatty Liver Disease (SMAFLD) and Simultaneous Metabolic and Alcohol-associated Steatohepatitis (SMASH)	5
Mediterranean diet or genome-based nutrition diets in Latin America's clinical practice guidelines for managing chronic liver diseases?	5
Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis	5
Weekend catch-up sleep is associated with the alleviation of non-alcoholic fatty liver disease	5
Causality imputation between herbal products and HILI: An algorithm evaluation in a systematic review	5
Body mass index implications in intrahepatic cholestasis of pregnancy and placental histopathological alterations	5
Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease	5
Turnera diffusa extract attenuates profibrotic, extracellular matrix and mitochondrial markers in activated human hepatic stellate cells (HSC)	5
Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseases	4
Differential capacity of CD90+ cells in autophagy activation following chemotherapy in hepatocellular carcinoma	4
Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents	4
Outbreak of hepatitis A in a post-vaccination era: High rate of co-infection with sexually transmitted diseases	4
Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC	4
Circ_0008285 knockdown represses tumor development by miR-384/RRM2 axis in hepatocellular carcinoma	4
LDL particle size and antioxidant HDL function improve after sustained virological response in patients with chronic HCV	4
Prevalence of fatty liver disease after liver transplantation and risk factors for recipients and donors	4
Hepatitis B infection in Mexican adults: Results of a nationally representative survey	4
Circular RNA hsa_circ_0098181 inhibits metastasis in hepatocellular carcinoma by activating the Hippo signaling pathway via interaction with eEF2	4
Maternal smoking during pregnancy is risk factor for gallbladder disease in offspring during adulthood: a prospective study from UK Biobank	4
Prevalence and risk factors of hepatitis C virus infection in the rural northeastern United States	4
Cost of illness of liver diseases in Japan	4
Economic evaluation of long-term albumin use in cirrhosis patients from the Mexican healthcare system perspective	4
Identification of key genes associated with the progression of liver fibrosis to hepatocellular carcinoma based on iTRAQ proteomics and GEO database	4
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists	4
The changing impact of pre-liver transplant renal dysfunction on post-transplant survival: results of 2 decades from a single center	4
Visualising and quantifying intestinal permeability -where do we stand	4
Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United States	4
Magnitude and genotype of hepatitis delta virus among chronic hepatitis B carriers with a spectrum of liver diseases in Ethiopia	4
Extrahepatic causes of death in cirrhosis compared to other chronic conditions in the United States, 1999-2017	4
A nomogram as an indirect method to identify sarcopenia in patients with liver cirrhosis	4
Global prevalence of occult HBV infection in children and adolescents: A systematic review and meta-analysis	4
From NAFLD to MASLD: When metabolic comorbidity matters	4
Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohort	4
Sinusoidal obstruction syndrome secondary the intake of Senecio brasiliensis: A case report	4
Safety and efficacy of common endoscopic treatments in patients with decompensated liver cirrhosis	4
Comparison of diagnostic performance of AFP, DCP and two diagnostic models in hepatocellular carcinoma: a retrospective study	4
High prevalence of periodontal disease in patients with NASH- possible association of poor dental health with NASH severity	4
Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and Europeans	4
Racial, ethnic, and socioeconomic disparities impact post-liver transplant survival in patients with hepatocellular carcinoma	4
Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations	4
The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia	4
Clinical characteristics of liver injury in SARS-CoV-2 Omicron variant- and Omicron subvariant-infected patients	4
Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases	4
HOXB13 facilitates hepatocellular carcinoma progression by activating AKT/mTOR signaling pathway	3
Circ_0000291 contributes to hepatocellular carcinoma tumorigenesis by binding to miR-1322 to up-regulate UBE2T	3
IL-18 discriminates highly frequent hepatitis E virus positive from negative blood donors in Mexico	3
Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir	3
Patients with alcohol-related liver disease hospitalized during the COVID-19 pandemic experienced worse outcomes	3
Liver fibrosis: More than meets the eye	3
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents	3
Assessment of hepatic fatty acids during non-alcoholic steatohepatitis progression using magnetic resonance spectroscopy	3
Seroprevalence of hepatitis B and C viruses in moderate and severe COVID-19 inpatients: A cross-sectional study at a referral center in Mexico	3
Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.)	3
Evolving portal hypertension through Baveno VII recommendations	3
Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination	3
Predictors of do-not-resuscitate order utilization in decompensated cirrhosis hospitalized patients: A nationwide inpatient cohort study	3
Circ_0005397 enhances hepatocellular carcinoma progression through miR-1283/HEG1	3
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis	3
Unexpected findings of hepatitis B and delta infection in northeastern Brazil: A public health alert	3
Laparoscopic repair of transected right hepatic artery during cholecystectomy: A report of two cases	3
A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis	3
Long-term prediction of hepatocellular carcinoma using serum autotaxin levels after antiviral therapy for hepatitis C	3
‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant	3
The potential mechanism of Chebulae Fructus in the treatment of hepatocellular carcinoma on the basis of network pharmacology	3
Post-hepatectomy liver failure prediction and prevention: Development of a nomogram containing postoperative anticoagulants as a risk factor	3
Aggressive recurrence of Non-Hodgkin's Lymphoma after successful clearance of hepatitis C virus with direct acting antivirals	3
VX-765 inhibits pyroptosis and reduces inflammation to prevent acute liver failure by upregulating PPARα expression	3
Late evening snack and oral amino acid capsules improved respiratory quotient and Fischer ratio in patients with alcoholic liver cirrhosis	3
Non-linear associations of circulating total bilirubin concentration with the risk of nonalcoholic fatty liver disease and all-cause mortality	3
Calling a stage-based treatment model for chronic liver diseases in China mainland	3
Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease	3
Nomogram for prediction of long-term survival with hepatocellular carcinoma based on NK cell counts	3
Clinical evaluation of modified ALPPS procedures based on risk-reduced strategy for staged hepatectomy	3
Spontaneous bacterial peritonitis has no effect on the long-term prognosis of cirrhosis patients with ascites	3
Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle	2
CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-κB pathway	2
“THE EFFECT OF GROWTH DIFFERENTIATION FACTOR 11 (GDF11) ON THE RESPONSE OF TUMOR-ASSOCIATED MACROPHAGES IN HEPATOCELLULAR CARCINOMA DERIVED CELLS”	2